Investors in Edtech

CRB is a private venture capital management firm dedicated to health technologies. Founded by a seasoned multi-disciplinary executive team, CRB has successfully launched three prior funds focusing on Biotech (Fund I), Medtech (Fund II), and Digital Health (Fund Nuubo). Currently, CRB is advancing with Fund III (CRB Digital Health III), which specializes in digital health. This fund is supported by a team with extensive experience spanning startups, scaleups, corporates, and public health institutions. Headquartered in Madrid and Barcelona, CRB strategically positions itself with access to Europe's most innovative hubs.

"Additio Investment Group is a global Syndicate of Healthcare & Life Sciences Investors that support high-integrity entrepreneurs with the potential to build great businesses. We pay particular attention to EU based opportunities that are in line with our health/care industry expertise and where we can add direct value, mainly: MedTech, and Digital Health/HealthTech with a particular clinical relevance. Average ticket size of €300-500K. AiG1 (fund 1) has been successfully allocated with a high profile portfolio of 5 companies. Our Partners are committed to hands-on value creation to our Portfolio through capital allocation, expertise and access to a valuable international Network."

Asabys Partners is a venture capital firm based in Barcelona that invests broadly in human healthcare. The firm is active in the health-tech and biopharma industries, targeting investments in Spain and internationally in highly innovative and transformative technologies. Motivated by the goal of pushing the boundaries of science and medicine, Asabys Partners sources and finances the most disruptive technologies and collaborates with top internal and external talents in the industry. With an entrepreneurial spirit, the firm seeks to be involved in the building and management of its companies, considering itself not just as investors, but as partners and collaborators to its portfolio companies.

The investment firm focuses on early-stage and growth-oriented companies located primarily within the region. They seek businesses with scalable ideas and clear competitive advantages, led by driven entrepreneurs willing to take significant risks. Emphasizing sustainability, they assess teams based on their diverse skills and experience. Investments are made through equity, convertible debentures, or Crown loans, with a preference for initiatives linked to growth in Halland and collaborations with Halmstad University. Initial investments typically start at SEK 500,000, with a maximum amount per company limited to one additional investment. Crown loans are offered up to SEK 500,000 annually per company, capped at SEK 250,000. Their investment strategy includes planning for potential exits within a six-year timeframe.

They partner with entrepreneurs and scientists who challenge conventional thinking and tackle complex problems. Their focus is on investing in innovative solutions with the potential to disrupt market structures. They prioritize businesses that embody agility, scalability, and sustainability in their operations and growth strategies.

Axilium Holding was established in Gothenburg, Sweden in 2018. Empowered with significant investment experience in several fields, a wide professional network, and a strong desire to succeed, the two founders established an innovative investment company focusing on early stage Technology and Life Science companies based predominantly in Europe.

Creandum, founded after the dotcom bubble and having thrived through the 2008/9 economic crisis, continues to invest steadily despite recent market conditions, believing top founders can emerge anytime. They've witnessed significant growth in the European tech market over 20 years. Now, they proudly announce the closing of Creandum VII, a €500m fund to support Europe's top Seed and Series A startups. Their disciplined, generalist approach focuses on partnering with the best entrepreneurs to build future global, category-defining companies.

Inbox Capital, based in Stockholm, Sweden, is a family-owned investment company specializing in disruptive and rapidly expanding technology sectors such as Fintech, Medtech, E-sports, B2B SaaS, and Deep Social Networks. Leveraging their own experience in building global businesses, they prioritize strong entrepreneurial leadership and persistence in the companies they invest in. They offer not just capital but also strategic advice and access to a broad network. With a focus on companies demonstrating a solid business model and significant growth metrics, their portfolio includes around 50 notable companies like VOI, Revolut, Truecaller, Meds, Acast, and Fishbrain.

Eir Ventures, based in the Nordic region, specializes in life sciences venture capital. With extensive experience and a strong network, they focus on investing in innovative medical solutions addressing critical unmet needs. Their team, renowned for managing over €4 billion in assets and achieving numerous successful exits, collaborates closely with universities and incubators to drive advancements in therapies, medical technology, and digital health.

We invest in promising cutting edge tech companies from Europe scaling to the moon. They are generation Y professionals sourcing and closing deals for top tier angels from across Europe.

Coinvest Capital invests in start-ups and companies undergoing business development and growth with groups of business angels.

Segulah Medical Acceleration specializes in investing in and nurturing transformative businesses focused on medical technologies and associated value chain solutions. These companies leverage cutting-edge research to develop real-world applications in areas like medical devices, diagnostics, and life science tools. Segulah Medical Acceleration plays a pivotal role in bridging the gap between innovative concepts and commercial validation, facilitating the global market entry of advanced medical research solutions.